Skip to content

Clinical trials

Completed Amyloidosis trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Status: Completed Country / region: Spain Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20081
20102
20133
20142
20151
20163
20171
20192
20202
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ionis Pharmaceuticals, Inc.6
Pfizer4
Alnylam Pharmaceuticals2
Bellus Health Inc. - a GSK company1
C.T. Development America, Inc.1
Eidos Therapeutics, a BridgeBio company1
Janssen Research & Development, LLC1
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.1
Neurimmune AG1
PETHEMA Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis22
Amyloid Neuropathies, Familial9
Alzheimer Disease5
Cardiomyopathies5
Immunoglobulin Light-chain Amyloidosis3
Polyneuropathies2
Amyloid Neuropathies1
Amyloidosis, Familial1
Arthritis, Rheumatoid1
Familial Mediterranean Fever1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.